BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24758301)

  • 1. Advanced glycation end product 3 (AGE3) suppresses the mineralization of mouse stromal ST2 cells and human mesenchymal stem cells by increasing TGF-β expression and secretion.
    Notsu M; Yamaguchi T; Okazaki K; Tanaka K; Ogawa N; Kanazawa I; Sugimoto T
    Endocrinology; 2014 Jul; 155(7):2402-10. PubMed ID: 24758301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis.
    Okazaki K; Yamaguchi T; Tanaka K; Notsu M; Ogawa N; Yano S; Sugimoto T
    Calcif Tissue Int; 2012 Oct; 91(4):286-96. PubMed ID: 22903508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.
    Notsu M; Kanazawa I; Takeno A; Yokomoto-Umakoshi M; Tanaka KI; Yamaguchi T; Sugimoto T
    Calcif Tissue Int; 2017 Apr; 100(4):402-411. PubMed ID: 28229177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products suppress osteoblastic differentiation of stromal cells by activating endoplasmic reticulum stress.
    Tanaka K; Yamaguchi T; Kaji H; Kanazawa I; Sugimoto T
    Biochem Biophys Res Commun; 2013 Aug; 438(3):463-7. PubMed ID: 23933252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.
    Ogawa N; Yamaguchi T; Yano S; Yamauchi M; Yamamoto M; Sugimoto T
    Horm Metab Res; 2007 Dec; 39(12):871-5. PubMed ID: 17960513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β-related mechanisms of bone destruction in multiple myeloma.
    Matsumoto T; Abe M
    Bone; 2011 Jan; 48(1):129-34. PubMed ID: 20570621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical demonstration of advanced glycation end products and the effects of advanced glycation end products in ossified ligament tissues in vitro.
    Yokosuka K; Park JS; Jimbo K; Yoshida T; Yamada K; Sato K; Takeuchi M; Yamagishi S; Nagata K
    Spine (Phila Pa 1976); 2007 May; 32(11):E337-9. PubMed ID: 17495767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β/BMP signaling pathway is involved in cerium-promoted osteogenic differentiation of mesenchymal stem cells.
    Liu DD; Zhang JC; Zhang Q; Wang SX; Yang MS
    J Cell Biochem; 2013 May; 114(5):1105-14. PubMed ID: 23150386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro.
    Chen C; Uludağ H; Wang Z; Jiang H
    J Cell Biochem; 2012 Dec; 113(12):3672-80. PubMed ID: 22740073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of pharmacological doses of dexamethasone on mineralization of mesenchymal progenitor cells in vitro.
    Shao J; Xu X; Li G; Zhang W; Qi J; Wang J; Cai M; Cui L; Zhang L; Zhao Q; Deng L
    Pharmazie; 2009 Oct; 64(10):674-9. PubMed ID: 19947171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.
    Li JH; Wang W; Huang XR; Oldfield M; Schmidt AM; Cooper ME; Lan HY
    Am J Pathol; 2004 Apr; 164(4):1389-97. PubMed ID: 15039226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
    Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
    J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient down-regulation of cbfa1/Runx2 by RNA interference in murine C3H10T1/2 mesenchymal stromal cells delays in vitro and in vivo osteogenesis, but does not overtly affect chondrogenesis.
    Gordeladze JO; Noël D; Bony C; Apparailly F; Louis-Plence P; Jorgensen C
    Exp Cell Res; 2008 Apr; 314(7):1495-506. PubMed ID: 18313048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells.
    Mikami Y; Omoteyama K; Kato S; Takagi M
    Biochem Biophys Res Commun; 2007 Oct; 362(2):368-73. PubMed ID: 17707772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin promotes osteoblast differentiation of human bone marrow stromal cells via bone morphogenetic protein signaling.
    Ying X; Sun L; Chen X; Xu H; Guo X; Chen H; Hong J; Cheng S; Peng L
    Eur J Pharmacol; 2013 Dec; 721(1-3):225-30. PubMed ID: 24076187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products affect growth and function of osteoblasts.
    Franke S; Rüster C; Pester J; Hofmann G; Oelzner P; Wolf G
    Clin Exp Rheumatol; 2011; 29(4):650-60. PubMed ID: 21906430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells.
    Tanaka K; Yamaguchi T; Kanazawa I; Sugimoto T
    Biochem Biophys Res Commun; 2015 May; 461(2):193-9. PubMed ID: 25721666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.